# Intrepid Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intrepid-labs

- Industry: Biotechnology
- Headquarters: Toronto, Canada
- Website: www.intrepidlabs.tech/
- Total disclosed funding: $7M
- Latest round: Seed (May 12, 2025)
- Investors on record: 1

## About

Based in Canada, Intrepid Labs focuses on optimizing drug discovery and delivery through advanced therapeutic solutions, utilizing machine learning and robotics to enhance pharmaceutical workflows.Intrepid Labs, founded in 2023 and headquartered in Toronto, Canada, develops innovative technology for drug discovery. The company has secured CAD 5.6 million in total funding, with the latest being a Seed round of CAD 9.8 million led by Avant Bio on May 12, 2025. They have completed one deal to date.Intrepid Labs specializes in developing advanced therapeutic solutions that enhance drug discovery and delivery processes. Their core offerings leverage active machine learning and robotics to streamline the design and manufacturing of next-generation drug products. This technology facilitates the rapid identification and formulation of molecular candidates, addressing critical challenges in drug development. Their products are primarily marketed to pharmaceutical companies and research institutions in North America and Europe.Intrepid Labs generates revenue through B2B collaborations with pharmaceutical companies and research organizations. Their model involves multi-year contracts that grant clients access to proprietary technology and services designed to enhance drug development capabilities. While specific pricing details are undisclosed, the revenue model is structured to ensure sustainable income through high-value contracts with key players in the pharmaceutical industry.Following their Seed funding round of CAD 9.8 million in May 2025, Intrepid Labs plans to use this capital to expand its workforce and develop initiatives for internal oral and long-acting injectables. The company aims to enhance its product offerings and is considering expansion into new geographical markets to broaden its reach.

## Funding rounds

- Seed, May 12, 2025, $7M — Avant Bio

## Investors

- Avant Bio (https://capitalatlas.ai/funds/avant-bio) — Seed